News & Analysis on Clinical Trial Services & Contract Research And Development
In March 2004, manufacturers of pharmaceuticals such as prescription painkillers and other drugs at risk of abuse were required to start using radiofrequency identification tags on all pallets destined for retail giant Wal-Mart, almost a year before...
A US company is gearing up to start trials of a novel drug that could provide the first orally-active treatment for a range of genetic disorders, including cystic fibrosis and muscular dystrophy, writes Phil Taylor.
A small German company has developed a new drug delivery technology that can transport active drugs into the interior of cells by an intrinsic, active mechanism.
India's Dr Reddy's Laboratories has acquired a US company that brings in a proprietary drug delivery technology that could be applied across a whole range of dermatological products.
Australia's Mayne Pharma has bought its way into the European market with the acquisition of a Germany company specialising in the manufacture of freeze dried and solution vial products for contract customers.
The company Evotec OAI, a drug discovery and development solution provider to the pharmaceutical and biotechnology industries has announced the successful expansion of their in vitro and in silico ADMET (Adsorption, Distribution, Metabolism, Excretion...
Despite reporting a decline in revenues, Germany's third-largest chemicalscompany Degussa said that it had 'got off to a solid start' in the firstquarter of the year, ahead of presenting its full results tomorrow.